Nasal boost with adjuvanted heat-killed BCG or arabinomannan–protein conjugate improves primary BCG-induced protection in C57BL/6 mice

This publication has 19 references indexed in Scilit:

• Correlation of virulence, lung pathology, bacterial load and delayed type hypersensitivity responses after infection with different Mycobacterium tuberculosis genotypes in a BALB/c mouse model
  Clinical and Experimental Immunology, 2004
• Immunization with heat-killed Mycobacterium bovis bacille Calmette–Guerin (BCG) in Eurocine™ L3 adjuvant protects against tuberculosis
  Vaccine, 2003
• A marked difference in pathogenesis and immune response induced by differentMycobacterium tuberculosisgenotypes
  Clinical and Experimental Immunology, 2003
• Mycobacterium tuberculosis arabinomannan–protein conjugates protect against tuberculosis
  Vaccine, 2003
• Boosting Vaccine for Tuberculosis
  Infection and Immunity, 2001
• Tuberculosis vaccine development: recent progress
  Trends in Microbiology, 2001
• Randomised controlled trial of single BCG, repeated BCG, or combined BCG and killed Mycobacterium leprae vaccine for prevention of leprosy and tuberculosis in Malawi
  The Lancet, 1996
• Variation in protection by BCG: implications of and for heterologous immunity
  The Lancet, 1995
• Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature
  JAMA, 1994
• Case-control study of the efficacy of BCG immunization against pulmonary tuberculosis in young adults in Santiago, Chile
  Tubercle and Lung Disease, 1992